Today, the fastest-moving firms often hold an edge. In late August 2018, shares of a small cancer-drug company called Geron Corporation soared 25 percent after its partner, Johnson & Johnson, posted a job listing. The opening suggested that a key regulatory decision for a drug the two companies were developing might be imminent, a piece of news that escaped all but those with the technology to instantly and automatically scour for job listings and similar real-time information.
